Pratley, R. E., et al. “Oral Semaglutide Reduces Hba And Body Weight In Patients With Type 2 Diabetes Regardless Of Background Glucose-Lowering Medication: Pioneer Subgroup Analyses.”. Diabetes Therapy : Research, Treatment And Education Of Diabetes And Related Disorders, pp. 1099-1116.